4//SEC Filing
Bonaccorso Joe 4
Accession 0001415889-24-022425
CIK 0001660334other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 4:15 PM ET
Size
7.5 KB
Accession
0001415889-24-022425
Insider Transaction Report
Form 4
Bonaccorso Joe
CHIEF COMMERCIAL OFFICER
Transactions
- Sale
Common Stock
2024-08-26$2.66/sh−24,709$65,726→ 82,107 total - Sale
Common Stock
2024-08-27$2.46/sh−8,993$22,123→ 73,114 total
Footnotes (3)
- [F1]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.53 inclusive.
Documents
Issuer
Verrica Pharmaceuticals Inc.
CIK 0001660334
Entity typeother
Related Parties
1- filerCIK 0001741973
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 4:15 PM ET
- Size
- 7.5 KB